Cipla has launched India’s first inhalable insulin
🔷Cipla has launched India’s first inhalable insulin, Afrezza, after receiving approval from the Central Drugs Standard Control Organisation…
🔷Cipla has launched India’s first inhalable insulin, Afrezza, after receiving approval from the Central Drugs Standard Control Organisation…
🔷Kidney disease means your kidneys aren’t working properly and are beginning to lose their function. Chronic kidney disease…
This breakthrough is incredibly promising and represents a monumental leap forward in the treatment of Type 1 diabetes.…